NOVEN PHARMS INC FDA Approval NDA 215401

NDA 215401

NOVEN PHARMS INC

FDA Drug Application

Application #215401

Documents

Letter2022-03-23
Label2022-03-25
Review2022-05-04

Application Sponsors

NDA 215401NOVEN PHARMS INC

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004

Application Products

001SYSTEM; TRANSDERMAL4.5MG/9HR0XELSTRYMDEXTROAMPHETAMINE
002SYSTEM; TRANSDERMAL9MG/9HR0XELSTRYMDEXTROAMPHETAMINE
003SYSTEM;TRANSDERMAL13.5MG/9HR0XELSTRYMDEXTROAMPHETAMINE
004SYSTEM;TRANSDERMAL18.5MG/9HR0XELSTRYMDEXTROAMPHETAMINE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2022-03-22STANDARD

Submissions Property Types

ORIG1Null7

CDER Filings

NOVEN PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215401
            [companyName] => NOVEN PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"XELSTRYM","activeIngredients":"DEXTROAMPHETAMINE","strength":"4.5MG\/9HR","dosageForm":"SYSTEM; TRANSDERMAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"XELSTRYM","activeIngredients":"DEXTROAMPHETAMINE","strength":"9MG\/9HR","dosageForm":"SYSTEM; TRANSDERMAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"XELSTRYM","activeIngredients":"DEXTROAMPHETAMINE","strength":"13.5MG\/9HR","dosageForm":"SYSTEM;TRANSDERMAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"XELSTRYM","activeIngredients":"DEXTROAMPHETAMINE","strength":"18.5MG\/9HR","dosageForm":"SYSTEM;TRANSDERMAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"03\/22\/2022","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2022\\\/215401s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"03\/22\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 3 - New Dosage Form","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2022\\\/215401s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2022\\\/215401Orig1s000ltr.pdf\"}]","notes":">"}]
            [supplements] => 
            [actionDate] => 2022-03-22
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.